van Santen HM - Search Results

1

Endocrine intervention during irradiation does not prevent damage to the thyroid gland.

van Santen HM, van Dijk JE, Rodermond H, Vansenne F, Endert E, de Vijlder JJ, Haveman J, Vulsma T. van Santen HM, et al. Among authors: van dijk je. Thyroid. 2006 Apr;16(4):387-95. doi: 10.1089/thy.2006.16.387. Thyroid. 2006. PMID: 16646686

2

High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.

van Santen HM, de Kraker J, van Eck BL, de Vijlder JJ, Vulsma T. van Santen HM, et al. Among authors: van eck bl. Cancer. 2002 Apr 1;94(7):2081-9. doi: 10.1002/cncr.10447. Cancer. 2002. PMID: 11932913 Free article.

3

Lower neonatal screening thyroxine concentrations in down syndrome newborns.

van Trotsenburg AS, Vulsma T, van Santen HM, Cheung W, de Vijlder JJ. van Trotsenburg AS, et al. Among authors: van santen hm. J Clin Endocrinol Metab. 2003 Apr;88(4):1512-5. doi: 10.1210/jc.2002-021303. J Clin Endocrinol Metab. 2003. PMID: 12679431

4

Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.

van Santen HM, de Kraker J, van Eck BL, de Vijlder JJ, Vulsma T. van Santen HM, et al. Among authors: van eck bl. Cancer. 2003 Jul 15;98(2):389-96. doi: 10.1002/cncr.11523. Cancer. 2003. PMID: 12872361 Free article.

5

No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer.

van Santen HM, Vulsma T, Dijkgraaf MG, Blumer RM, Heinen R, Jaspers MW, Geenen MM, Offringa MO, de Vijlder JJ, van den Bos C. van Santen HM, et al. Among authors: van den bos c. J Clin Endocrinol Metab. 2003 Aug;88(8):3657-63. doi: 10.1210/jc.2003-030209. J Clin Endocrinol Metab. 2003. PMID: 12915651

6

Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience.

van Santen HM, Aronson DC, Vulsma T, Tummers RF, Geenen MM, de Vijlder JJ, van den Bos C. van Santen HM, et al. Among authors: van den bos c. Eur J Cancer. 2004 Jul;40(11):1743-51. doi: 10.1016/j.ejca.2004.03.006. Eur J Cancer. 2004. PMID: 15251165

7

Changes in thyroid hormone state in children receiving chemotherapy.

van Santen HM, Thonissen NM, de Kraker J, Vulsma T. van Santen HM, et al. Clin Endocrinol (Oxf). 2005 Feb;62(2):250-7. doi: 10.1111/j.1365-2265.2005.02210.x. Clin Endocrinol (Oxf). 2005. PMID: 15670204

8

Disseminated medullary thyroid carcinoma despite early thyroid surgery in the multiple endocrine neoplasia-2A syndrome.

van Santen HM, Aronson DC, van Trotsenburg AS, ten Kate FJ, van de Wetering MD, Wiersinga WM, de Vijlder JJ, Vulsma T. van Santen HM, et al. Among authors: van de wetering md, van trotsenburg as. Thyroid. 2005 May;15(5):485-8. doi: 10.1089/thy.2005.15.485. Thyroid. 2005. PMID: 15929671

9

The effect of cervical X-irradiation on activity index of thyrocytes and plasma TSH: a pre-clinical model for radiation-induced thyroid damage.

van Santen HM, Van Dijk JE, Rodermond H, Vansenne F, Meertens N, Haveman J, Endert E, De Vijlder JJ, Vulsma T. van Santen HM, et al. Among authors: van dijk je. J Endocrinol Invest. 2005 Mar;28(3):261-9. doi: 10.1007/BF03345383. J Endocrinol Invest. 2005. PMID: 15952412

10

Endocrine late effects from multi-modality treatment of neuroblastoma.

van Santen HM, de Kraker J, Vulsma T. van Santen HM, et al. Eur J Cancer. 2005 Aug;41(12):1767-74. doi: 10.1016/j.ejca.2005.02.036. Eur J Cancer. 2005. PMID: 16039114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters